CVE-2012-6671: Multiple cross-site scripting (XSS) vulnerabilities in actions/main.php in the DragonByte Technologies Forumon
CVE-2012-6671 is a medium-severity flaw (CVSS 6.1) affecting forumon rpg module. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Multiple cross-site scripting (XSS) vulnerabilities in actions/main.php in the DragonByte Technologies Forumon RPG module before 1.0.8 for vBulletin when creating a new monster, allow remote attackers to inject arbitrary web script or HTML via the (1) monster[title] or (2) monster[description] parameters.
Why this priority
- No elevated risk signals yet
A fixed release or distro patch exists.
Risk facts
| CVSS score | 6.1 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | None |
| User interaction | Required |
| EPSS exploit chance | 1.6% (top 24%) |
| CISA exploited list | No |
| Weakness | CWE-79 |
| Published | 2018-01-11 |
| Last modified | 2026-06-16 |
Last updated 2026-06-16 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2012-6671?
forumon rpg module: upgrade to 1.0.8. Exact commands for each OS are on this page.
Is CVE-2012-6671 being exploited?
CVE-2012-6671 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2012-6671 affect?
CVE-2012-6671 affects forumon rpg module. Severity is medium (CVSS 6.1). Multiple cross-site scripting (XSS) vulnerabilities in actions/main.php in the DragonByte Technologies Forumon RPG module before 1.0.8 for vBulletin when creating a new monster, allow remote attackers to inject arbitrary web script or HTML
How urgent is CVE-2012-6671?
Priority 40/100. No elevated risk signals yet.